Subclinical Pancreas Rejection on Protocol Biopsy Within the First Year of Simultaneous Pancreas Kidney Transplant
Clinical Transplantation · 2024-10 · 38 (10)
DOI: 10.1111/ctr.15467 ↗At a glance
Studienprotokoll in Clinical Transplantation, published online on 2024-09-26. Written by Pooja Budhiraja and 13 co-authors. Institution: Department of Medicine, Mayo Clinic Arizona, Phoenix, Arizona, USA. Major MEDLINE topics: Graft Rejection, Pancreas Transplantation, Kidney Transplantation, Graft Survival. Cited 5 times so far (Crossref); 13 references.
Abstract (original language)
This single‐center retrospective study investigated subclinical rejection prevalence and significance in simultaneous pancreas and kidney transplant (SPKT) recipients. We analyzed 352 SPKT recipients from July 2003 to April 2022. Our protocol included pancreas allograft surveillance biopsies at 1, 4, and 12months post‐transplant. After excluding 153 patients unable to undergo pancreas biopsy, our study cohort comprised 199 recipients. Among the 199 patients with protocol pancreas biopsies, 107 had multiple protocol pancreas biopsies in the first year, totaling 323. Subclinical rejection was identified in 132 episodes (41%). Of these, 72% were Grade 1, 20% were indeterminate, and 8% were Banff Grade 2 or higher. All episodes of subclinical rejection were treated. Rates of pancreas graft loss (10% vs. 7%) and clinical rejection (21% vs. 20%) at 3 years were similar between those with and without subclinical rejection. Subclinical rejection Banff Grade 2 or more was associated with poor pancreas graft survival HR of 5.5 (95% CI: 1.24–24.37, p = 0.025). Of 236 simultaneous protocol kidney and pancreas biopsies, 102 (43%) showed pancreas subclinical rejection, while only 17% had concurrent kidney subclinical rejection. Our findings suggest limited predictive value of pancreatic enzymes and euglycemia in detecting pancreas rejection. Furthermore, poor concordance existed between pancreas and kidney subclinical rejection.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Department of Medicine, Mayo Clinic Arizona, Phoenix, Arizona, USA.
- Division of Statistics, Mayo Clinic Arizona, Phoenix, Arizona, USA.
- Department of Surgery, Mayo Clinic Arizona, Phoenix, Arizona, USA.
- Department of Laboratory Medicine and Pathology, Mayo Clinic Arizona, Phoenix, Arizona, USA.
ORCID profiles: Pooja Budhiraja, Raymond L Heilman, Richard Butterfield, Kunam S Reddy, Hassan A Khamash, Bassam G Abu Jawdeh, Caroline C Jadlowiec, Nitin Katariya, Maxwell Smith, Andres Jaramillo, Amit Mathur, Katrin Hacke, Harini A Chakkera
Cite
APA
Budhiraja, P., Heilman, R. L., Butterfield, R., Reddy, K. S., Khamash, H. A., Abu Jawdeh, B. G., Jadlowiec, C. C., Katariya, N., Smith, M., Jaramillo, A., Alajous, S., Mathur, A., Hacke, K., & Chakkera, H. A. (2024). Subclinical Pancreas Rejection on Protocol Biopsy Within the First Year of Simultaneous Pancreas Kidney Transplant. Clinical Transplantation, 38(10). https://doi.org/10.1111/ctr.15467
Vancouver
Budhiraja P, Heilman RL, Butterfield R, Reddy KS, Khamash HA, Abu Jawdeh BG, et al. Subclinical Pancreas Rejection on Protocol Biopsy Within the First Year of Simultaneous Pancreas Kidney Transplant. Clinical Transplantation. 2024;38(10). doi:10.1111/ctr.15467
BibTeX
@article{Budhiraja2024,
author = {Budhiraja, Pooja and Heilman, Raymond L and Butterfield, Richard and Reddy, Kunam S and Khamash, Hassan A and Abu Jawdeh, Bassam G and Jadlowiec, Caroline C and Katariya, Nitin and Smith, Maxwell and Jaramillo, Andres and Alajous, Salah and Mathur, Amit and Hacke, Katrin and Chakkera, Harini A},
title = {Subclinical Pancreas Rejection on Protocol Biopsy Within the First Year of Simultaneous Pancreas Kidney Transplant},
journal = {Clinical Transplantation},
year = {2024},
volume = {38},
number = {10},
doi = {10.1111/ctr.15467}
}
EUVIMED